Schizophrenia Relapse Reduction Disease Management Program – New Resources Released By Frameworks In Health & Quality Gettysburg, PA, Sept. 30, 2017 (GLOBE NEWSWIRE) -- OPEN MINDS announced Otsuka Pharmaceutical Development & Commercialization, Inc. has released a new Frameworks in Health and Quality program,...

Frameworks In Health & Quality Program & OPEN MINDS Collaborate To Present Best Practices In Schizophrenia Relapse Reduction – Free Executive Web Briefing Gettysburg, PA, Sept. 05, 2017 (GLOBE NEWSWIRE) -- The risk of relapse is great for those diagnosed with schizophrenia, with the 1-year rate as high as 50% and the 5 year rate as high as 80% –...